Anticonvulsant effects of the 3-hydroxyanthranilic acid dioxygenase inhibitor NCR-631

Amino Acids

Volumn 19, Issue 1, 2000, Pages 325-334

  Luthman, J ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Amino acids; Epilepsy; Kynurenines; Quinolinic acid; Seizures

Indexed keywords

3 HYDROXYANTHRANILIC ACID; 4,6 DIBROMO 3 HYDROXYANTHRANILIC ACID; AMINO ACID; ANTICONVULSIVE AGENT; KYNURENINE; NCR 631; OXYGENASE; PENTETRAZOLE; QUINOLINIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; EPILEPTOGENESIS; GRAND MAL SEIZURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; TONIC CLONIC SEIZURE;

ANIMALIA;

EID: 0033800644     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007260070063     Document Type: Article

References (28)

1. Quinolinic acid accumulation and functional deficits following experimental spinal cord injury
2. Inhibitors of kynureine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activites
3. Nicotinylalanine increases cerebral kynurenic acid and content and has anticonvulsant activity
4. Differential expression of the astrocytic enzymes 3-hydroxyanthranilic acid oxygenase, kynurenine amino-transferase and glutamine synthetase in seizure-prone and non-epileptic mice
5. Quinolinic-phosphoribosyl transferase activity is decreased in epileptic human brain tissue
6. Animal models of the epilepsies
7. 3-Hydroxyanthranilic acid accumulation following administration of the 3-hydroxyanthranilic acid dioxygenase inhibitor NCR-631
8. Quinolinic acid concentrations in brain and cerebrospinal fluid of patients with intractable complex partial seizures
9. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease
10. Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures
11. Localization of quinolinic acid metabolizing enzymes in the rat brain. Immunohistochemical studies using antibodies to 3-hydroxyanthranilic acid oxygenase and quinolinic acid phosphoribosyltransferase
12. Stimulant and convulsant effects of kynurenines injected into brain ventricles in mice
13. Synthesis and QSAR of substituted 3-hydroxyanthranilic acid derivatives as inhibitors of 3-hydroxyanthranilic acid dioxygenase (3-HAO)
14. Regulation of quinolinic acid in the normal rat brain by kynurenine pathway precursors
15. Effects of the 3-hydroxyanthranilic acid analogue NCR-631 on anoxia-, IL-1β,- and LPS-induced hippocampal cell loss in vitro
16. Quinolinic acid: Supportive observations on its possible role as an endogenous excitotoxin in epilepsy
17. Molecular cloning and functional expression of human 3-hydroxyanthranilic-acid dioxygenase
18. Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure
19. Increases in the level of mRNA for 3-hydroxyanthranilate 3,4-dioxygenase in brain of epilepsy-prone El mice
20. Abnormally high activity of 3-hydroxyanthranilate-3-,4-dioxygenase in brain of epilepsy-prone El mice
21. High levels of quinolinic acid in brain of epilepsy-prone El mice
22. Rat 3-hydroxyanthranilic acid oxygenase: Purification from the liver and immunocytochemical localization in the brain
23. Modification of seizure activity by electrical stimulation. II. Motor seizure
24. Genetics of audiogenic seizures. 1. Relation to brain serotonin and norepinephrine in mice
25. Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain
26. Seizure activity and lesions after intrahippocampal quinolinic acid injection
27. Neuropharmacology of quinolinic and kynurenic acids
28. Electrical kindling is associated with a lasting increase in the extracellular levels of kynurenic acid in the rat hippocampus